COHR offering to raise $50 million
Independent service organization COHR of Chatsworth, CA, has fileda registration statement with the Securities and Exchange Commissionfor a secondary stock offering of 1.9 million shares. At COHR'scurrent stock price of $26.50 a share, the offering would
Independent service organization COHR of Chatsworth, CA, has fileda registration statement with the Securities and Exchange Commissionfor a secondary stock offering of 1.9 million shares. At COHR'scurrent stock price of $26.50 a share, the offering would raiseover $50 million. The company will offer 1.5 million shares ofstock, while 400,000 shares will be sold by existing stockholders.
COHR did not indicate what it planned to use the money for,but the ISO has been growing rapidly in the past two years, primarilythrough acquisition. It bought MRI service company Vision MedicalServices in May (SCAN 5/22/96). COHR chief executive Paul Choprahas stated that the company is planning further acquisitions asthe ISO industry consolidates.
In other news, COHR last month moved to a new office in Chatsworth,from its previous headquarters in Los Angeles. The new facilityincludes 80,000 square feet of office space and enables COHR tounify its three main operating divisions for the first time.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
